Medieos Lifesciences LLP

Atorvastatin is a medication used to lower high cholesterol and triglyceride levels in the blood. It belongs to a class of drugs called statins, which work by blocking an enzyme involved in cholesterol production in the liver. Atorvastatin helps reduce the risk of heart disease, stroke, and other cardiovascular conditions. It is often prescribed to patients with high cholesterol, diabetes, or a history of heart problems to maintain healthy blood vessels and improve heart health.

Atorvastatin is a medication used to lower high cholesterol and triglyceride levels in the blood. It belongs to a class of drugs called statins, which work by blocking an enzyme involved in cholesterol production in the liver. Atorvastatin helps reduce the risk of heart disease, stroke, and other cardiovascular conditions. It is often prescribed to patients with high cholesterol, diabetes, or a history of heart problems to maintain healthy blood vessels and improve heart health.

Atorvastatin is a medication used to lower high cholesterol and triglyceride levels in the blood. It belongs to a class of drugs called statins, which work by blocking an enzyme involved in cholesterol production in the liver. Atorvastatin helps reduce the risk of heart disease, stroke, and other cardiovascular conditions. It is often prescribed to patients with high cholesterol, diabetes, or a history of heart problems to maintain healthy blood vessels and improve heart health.

• Controls Type 2 Diabetes Mellitus effectively.
•  Lowers fasting and post-meal blood sugar levels. 
• Improves insulin sensitivity and glucose utilization. 
• Stimulates pancreas to release adequate insulin. 
• Reduces risk of diabetes-related complications. 
• Supports long-term sugar control when used with diet & exercise.

• Hypersensitivity to alpha ketoanalogue or excipients

• Potassium supplements: May increase risk of hyperkalemia

• ACE inhibitors / ARBs: Monitor potassium levels

• Minimal interactions with most medications, as it is a nutritional supplement

• Generally considered safe as a nutritional supplement

• Use under physician supervision

• Safe for mothers, minimal systemic exposure

• Used in children with CKD under nephrologist supervision

• Dose adjusted based on weight and nutritional status

• Supports renal nutrition in elderly CKD patients

• Monitor renal function, electrolytes, and nutritional status

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid humid or bathroom storage

• Hypersensitivity to alpha ketoanalogue or excipients

• Severe electrolyte imbalance

• Advanced CKD requiring immediate dialysis

• Potassium supplements: May increase risk of hyperkalemia

• ACE inhibitors / ARBs: Monitor potassium levels

• Minimal interactions with most medications, as it is a nutritional supplement

• Generally considered safe as a nutritional supplement

• Use under physician supervision

• Safe for mothers, minimal systemic exposure

• Monitor infant growth and nutrition

• Used in children with CKD under nephrologist supervision

• Dose adjusted based on weight and nutritional status

• Supports renal nutrition in elderly CKD patients

• Monitor renal function, electrolytes, and nutritional status

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid humid or bathroom storage

To provide renal nutritional support and delay CKD progression in pre-dialysis patients.

Supply essential amino acids in keto form, reducing nitrogen accumulation and kidney workload.

Yes, under nephrologist supervision, particularly in CKD stages 3–5.

With meals and a low-protein diet as prescribed by a physician.

• Effective and sustained blood pressure control

• Reduces risk of heart disease and stroke

• Protects kidneys and blood vessels

• Improves heart function

• Suitable for long-term therapy

• Available in multiple strengths and combinations

• Dosage is determined by a healthcare professional

• Usually taken once or twice daily

• Some blood pressure medicines are unsafe during pregnancy

• Use only under medical supervision

• Consult a doctor before use

• Lower starting doses may be recommended

• Should be taken at the same time each day

They are used to control high blood pressure and prevent complications.

Yes, they are meant for daily long-term use.

Initial effects may be seen within days, but full benefit takes a few weeks.

No, stopping suddenly may cause BP to rise again.

No, they are not habit-forming.

Some people may feel dizziness initially.

Most can be taken with or without food.

Yes, with proper dose adjustment.

Alcohol should be limited.

Yes, they reduce the risk of heart disease.

They protect kidneys when used correctly.

Yes, it is very important.

Some medicines may cause ankle swelling.

Yes, under medical supervision.

Combination tablets may provide better BP control in some patients.

• NSAIDs, Sulfonamides, Antibiotics: May increase hypoglycemia risk.

• Corticosteroids, Thyroid Hormones: May reduce hypoglycemic effect.

• Alcohol: Increases risk of delayed hypoglycemia.

• Beta-blockers: May mask hypoglycemia symptoms.

• Children (<18 years): Safety not well established.

• Elderly: Lower starting dose recommended; monitor closely.

• Pregnancy: Insulin preferred; Glimepiride generally avoided.

• Breastfeeding: Small amounts may pass into milk; consult physician.

• Follow a diabetic diet and lifestyle plan.

• Engage in regular exercise.

• Avoid skipping meals to reduce hypoglycemia risk.

• Monitor blood glucose regularly.

• Maintain hydration and moderate alcohol intake.

• Store in a cool, dry place (<25°C).

• Protect from light and moisture.

• Keep out of reach of children.

• Do not use past expiration date.

It is used to control blood sugar in type 2 diabetes patients.

Yes, as monotherapy for patients not adequately controlled with diet and exercise.

Yes, often combined with Metformin, DPP-4 inhibitors, or SGLT2 inhibitors.

Once daily, preferably before breakfast, with water.

Take as soon as remembered; skip if near the next dose.

Yes, especially if meals are skipped or alcohol is consumed.

Yes, with careful monitoring and dose adjustment.

Not recommended for patients under 18.

Generally avoided; insulin preferred.

Alcohol increases hypoglycemia risk; avoid excessive intake.

Yes, but monitor for hypoglycemia symptoms.

Mild weight gain may occur due to insulin effect.

Yes, caution advised in severe hepatic or renal impairment.

Blood glucose reduction may be observed within hours; optimal effect in 1–2 weeks.

Discontinue only under medical supervision to avoid hyperglycemia.

It is used to control blood sugar in patients with type 2 diabetes mellitus.

It is a combination therapy; individual components may be used as monotherapy.

Yes, under medical supervision, often with DPP-4 inhibitors, SGLT2 inhibitors, or insulin.

With meals, swallowed whole with water.

Take as soon as remembered; skip if near the next scheduled dose.

Yes, particularly due to Glimepiride; monitor meals and glucose.

Yes, with lower starting doses and monitoring.

Not recommended under 18 years.

Generally avoided; insulin preferred.

Alcohol increases risk of hypoglycemia and lactic acidosis; avoid excessive consumption.

Yes, but monitor for hypoglycemia.

Glimepiride may cause mild weight gain; Metformin is generally weight-neutral.

Blood glucose reduction is observed within hours; maximum effect in 1–2 weeks.

Yes, monitor renal and hepatic parameters regularly.

Discontinue only under medical supervision.

• Controls Type 2 Diabetes Mellitus effectively.
•  Lowers fasting and post-meal blood sugar levels. 
• Improves insulin sensitivity and glucose utilization. 
• Stimulates pancreas to release adequate insulin. 
• Reduces risk of diabetes-related complications. 
• Supports long-term sugar control when used with diet & exercise

• Controls Type 2 Diabetes Mellitus effectively.
•  Lowers fasting and post-meal blood sugar levels. 
• Improves insulin sensitivity and glucose utilization. 
• Stimulates pancreas to release adequate insulin. 
• Reduces risk of diabetes-related complications. 
• Supports long-term sugar control when used with diet & exercise.

Glimepiride and Metformin HCl Tablets are a fixed-dose combination (FDC) oral antidiabetic therapy widely used for the management of type 2 diabetes mellitus (T2DM). This combination combines the complementary mechanisms of two highly effective antidiabetic agents:

• Glimepiride – A sulfonylurea that stimulates pancreatic insulin secretion and enhances peripheral insulin sensitivity.

• Metformin HCl – A biguanide that reduces hepatic glucose production and improves peripheral glucose uptake.

Each Glimepiride and Metformin HCl Tablet typically contains:

• Glimepiride – 1 mg / 2 mg / 4 mg (depending on the formulation)

• Metformin HCl – 500 mg / 850 mg / 1000 mg (depending on the formulation)

• Excipients – q.s. (pharmacologically inactive ingredients for stability, manufacturability, and patient acceptability)

Common excipients include:

• Binders (e.g., microcrystalline cellulose)

• Disintegrants (e.g., croscarmellose sodium)

• Lubricants (e.g., magnesium stearate)

• Fillers (e.g., lactose monohydrate)

• Film coating agents (e.g., hydroxypropyl methylcellulose, colorants)

These excipients ensure tablet integrity, uniformity, bioavailability, and ease of administration.

• Drug Class: Combination of Sulfonylurea + Biguanide

• Therapeutic Category: Antidiabetic / Oral Hypoglycemic Agent

• Mechanism of Action Class: Insulin secretagogue + Insulin sensitizer

The Glimepiride and Metformin HCl combination acts through dual complementary mechanisms:

• Stimulates pancreatic beta cells to release insulin in a glucose-dependent manner.

• Enhances peripheral glucose uptake, improving insulin sensitivity.

• Reduces both fasting and postprandial hyperglycemia.

• Inhibits hepatic gluconeogenesis, reducing glucose production in the liver.

• Enhances peripheral glucose uptake in muscle and adipose tissue.

• Improves insulin sensitivity without stimulating insulin secretion, minimizing hypoglycemia risk.

• Synergistic reduction in fasting and postprandial blood glucose.

• Complementary action allows smaller doses of each component, reducing adverse effects.

• Improves glycemic control in patients inadequately controlled on monotherapy.

Glimepiride and Metformin HCl Tablets are indicated for

It is used to control blood sugar in patients with type 2 diabetes mellitus.

It can be used as monotherapy or with other antidiabetic drugs or insulin under supervision.

With meals, swallowed whole with water.

Yes, primarily due to Glimepiride. Monitor meals and blood glucose.

Yes, with careful dose adjustment and monitoring.

Safety in children under 18 is not established.

Excessive alcohol increases risk of hypoglycemia and lactic acidosis; avoid.

Sitagliptin tablet is used to manage type 2 diabetes by helping control blood sugar levels. It works by increasing insulin release and decreasing the amount of sugar produced by the liver, especially after meals. Sitagliptin belongs to a class of drugs called DPP-4 inhibitors and is often used along with diet, exercise, or other diabetes medications. It helps reduce the risk of complications related to diabetes and supports better long-term glucose control.

Rosuvastatin is a statin medication used primarily to lower cholesterol levels and reduce the risk of cardiovascular disease. It works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver. Rosuvastatin effectively lowers low-density lipoprotein (LDL or "bad" cholesterol), raises high-density lipoprotein (HDL or "good" cholesterol), and reduces triglycerides.

The main benefits of rosuvastatin include preventing heart attacks, strokes, and other cardiovascular events, especially in individuals with high cholesterol, diabetes, or a history of heart disease. It is also used in familial hypercholesterolemia, a genetic condition that causes dangerously high cholesterol levels. Rosuvastatin is generally well-tolerated, with common side effects including muscle pain and mild digestive issues.

Its potent lipid-lowering effects and once-daily dosing make rosuvastatin a convenient and effective choice for long-term management of cholesterol and cardiovascular risk, especially when lifestyle changes alone are insufficient.

L-Carnitine is a naturally occurring amino acid derivative that plays a crucial role in energy production by transporting fatty acids into the mitochondria, where they are burned for fuel. It is commonly used as a dietary supplement to support fat metabolism, enhance physical performance, and aid in recovery after exercise.

One of its primary benefits is improving exercise endurance and reducing fatigue, especially in athletes or individuals with low energy levels. L-Carnitine is also used in weight management programs as it may help the body utilize fat more efficiently. In medical settings, it is beneficial for patients with certain heart conditions, such as angina and heart failure, as it improves cardiac energy metabolism. It may also support brain function and reduce symptoms in conditions like Alzheimer’s or age-related cognitive decline.

Generally well-tolerated, L-Carnitine is considered safe when used appropriately and can be an effective supplement for energy, metabolism, and cardiovascular support.

• Hypersensitivity to alpha ketoanalogue or excipients

• Severe electrolyte imbalance

• Advanced CKD requiring immediate dialysis

• Potassium supplements: Risk of hyperkalemia

• ACE inhibitors / ARBs: Monitor potassium

• Minimal interactions as it is a nutritional supplement

• Generally safe; consult physician

• Safe; minimal systemic exposure

• Monitor infant nutrition

• Use under nephrologist supervision

• Dose based on weight and CKD stage

• Monitor renal function and electrolytes

• Supports nutrition in elderly CKD patients

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid humid areas

To support renal nutrition and delay CKD progression in pre-dialysis patients.

Provide essential amino acids in keto form, reducing nitrogen accumulation on kidneys.

Yes, under nephrologist supervision, especially for CKD stages 3–5.

With meals, in combination with a low-protein diet.

Mild gastrointestinal discomfort is common; serious side effects are rare.

Yes, under pediatric nephrologist supervision with weight-based dosing.

Yes, under physician supervision.

Yes, but monitor electrolytes and renal function.

At 25°C, away from light and moisture, in original packaging.

Yes, bulk packs are available.

No, they are supplementary therapy for nutrition and renal support.

Yes, typically 600 mg per tablet; packaging may vary.

Mostly for pre-dialysis; consult nephrologist for dialysis patients.

Yes, with renal function and electrolyte monitoring.

Yes, they are specifically designed to support low-protein diets in CKD.

• NSAIDs: Reduce antihypertensive efficacy.

• Potassium supplements/Diuretics: Monitor serum potassium.

• Other antihypertensives: May enhance BP-lowering effect.

• CYP450 substrates: Check interactions with beta-blockers and CCBs.

• Alcohol: May potentiate hypotensive effects.

• Children: Safety and efficacy vary by drug.

• Elderly: Start low, titrate slowly.

• Pregnancy: Avoid ACE inhibitors/ARBs.

• Breastfeeding: Most drugs compatible with caution; check individual agents.

• Reduce salt intake.

• Maintain healthy weight.

• Engage in regular aerobic exercise.

• Avoid smoking and excessive alcohol.

• Monitor BP at home and follow up regularly.

• Store in a cool, dry place (<25°C).

• Protect from light and moisture.

• Keep out of reach of children.

• Do not use past expiration date.

To lower high blood pressure and reduce the risk of heart attack, stroke, and kidney disease.

Yes, most antihypertensives are safe for lifelong use under medical supervision.

Yes, often required if BP is not controlled with monotherapy.

Follow prescribed dose, usually once daily; with or without food depending on the drug.

Yes, but monitor for dizziness or hypotension.

Yes, monitor symptoms like dizziness, fainting, or fatigue.

Yes, diet, exercise, and weight control are critical for effective BP management.

Alcohol may enhance hypotensive effects; moderation is advised.

ACE inhibitors and ARBs are contraindicated; consult your doctor.

No, sudden discontinuation may cause BP spikes; taper under doctor supervision.

Rarely, especially ACE inhibitors/ARBs in patients with preexisting kidney disease; regular monitoring required.

Take as soon as remembered, unless close to the next dose.

Inform your doctor about all medications to avoid interactions.

Yes, especially diuretics; monitor sodium, potassium, and magnesium levels.

BP reduction may begin within hours (CCBs/diuretics) or days (ACE inhibitors/ARBs). Full effect usually seen within 2–4 weeks.